(2ïS,5R)-1-{2ï-[(TERT.-BUTOXYCARBONYL)-METHYL]-3ï-PHENYLPROPIONYL}-3,3,5-TRIMETHYLPYRROLIDIN-2-ONE
Compound with spectra: 1 NMR
![(2ïS,5R)-1-{2ï-[(TERT.-BUTOXYCARBONYL)-METHYL]-3ï-PHENYLPROPIONYL}-3,3,5-TRIMETHYLPYRROLIDIN-2-ONE](/api/compound/oZ64ex8v5c.png?ph=true&h=300&w=458 "(2ïS,5R)-1-{2ï-[(TERT.-BUTOXYCARBONYL)-METHYL]-3ï-PHENYLPROPIONYL}-3,3,5-TRIMETHYLPYRROLIDIN-2-ONE")
| SpectraBase Compound ID | oZ64ex8v5c |
|---|---|
| InChI | InChI=1S/C22H31NO4/c1-15-14-22(5,6)20(26)23(15)19(25)17(12-16-10-8-7-9-11-16)13-18(24)27-21(2,3)4/h7-11,15,17H,12-14H2,1-6H3/t15-,17-/m1/s1 |
| InChIKey | LBKDSXWXEPEYIJ-NVXWUHKLSA-N |
| Mol Weight | 373.49 g/mol |
| Molecular Formula | C22H31NO4 |
| Exact Mass | 373.225308 g/mol |
| Enantiomer InChIKey | LBKDSXWXEPEYIJ-RDJZCZTQSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-(3-bromanyl-4-methyl-phenyl)-3-[(4-chlorophenyl)methyl]pyrrolidine-2,5-dione
3-(Phenylmethyl)-1-[3-(trifluoromethyl)phenyl]pyrrolidine-2,5-dione
(3R,4R)-1,4-dibenzyl-5-keto-pyrrolidine-3-carboxylic acid methyl ester
(4R)-N-[(2S)-2-METHYL-1-OXO-3-PHENYLPROPYL]-5,5-DIMETHYL-4-ISOPROPYLOXAZOLIDIN-2-ONE
(5S)-1,5-DIBENZYL-3-PHENYLPYRROLIDIN-2-ONE
2-(2-Naphthylmethyl)-N-phenyl-succinimide
3-methyl-4-(4-methylbenzyl)-1-[4-(trifluoromethoxy)phenyl]-2,5-pyrrolidinedione
(3S,CIS)-6-(1H-IMIDAZOL-4-YL-METHYL)-1-METHYL-3-(PHENYLMETHYL)-PIPERAZINE-2,5-DION
N-[(Cyclohexylamino)carbonyl]-N-cyclohexyl-2-ethyl-3-hydroxy-3-phenylpropanamide
(1R*, 3R*) 1,4-Dibenzyl-4-azaspiro[2.4]heptan-5-one
| Title | Journal or Book | Year |
|---|---|---|
| First asymmetric synthesis of the Kelatorphan-like enkephalinase inhibitor (1S,2R,2′S )-2-[2′-(N-hydroxycarbamoylmethyl)-3′-phenylpropionylamino]cyclohexane-1-carboxylic acid | Journal of the Chemical Society, Perkin Transactions 1 | 1998 |